Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.

Asai S, Miura N, Sawada Y, Noda T, Kikugawa T, Tanji N, Saika T.

Oncol Lett. 2018 Jan;15(1):522-527. doi: 10.3892/ol.2017.7269. Epub 2017 Oct 26.

2.

Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.

Takahashi A, Imaizumi H, Hayashi M, Okai K, Abe K, Usami K, Tanji N, Ohira H.

Sports Med Int Open. 2017 Jan 31;1(1):E2-E7. doi: 10.1055/s-0042-117875. eCollection 2017 Jan.

3.

Primary adrenal leiomyosarcoma with lymph node metastasis: a case report.

Onishi T, Yanagihara Y, Kikugawa T, Miura N, Noda T, Kakuda T, Kitazawa R, Tanji N.

World J Surg Oncol. 2016 Jul 2;14(1):176. doi: 10.1186/s12957-016-0936-z.

4.

[Visceral metastases].

Yanagihara Y, Tanji N.

Nihon Rinsho. 2016 May 20;74 Suppl 3:154-8. Japanese. No abstract available.

PMID:
27344721
5.

Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate Cancer.

Miura N, Tanji N, Yanagihara Y, Noda T, Asai S, Nishimura K, Shirato A, Miyauchi Y, Kikugawa T, Yokoyama M.

Chemotherapy. 2016;61(1):23-31. doi: 10.1159/000440942. Epub 2015 Nov 4.

PMID:
26528957
6.

The Association between Sleep Duration and Non-Alcoholic Fatty Liver Disease among Japanese Men and Women.

Imaizumi H, Takahashi A, Tanji N, Abe K, Sato Y, Anzai Y, Watanabe H, Ohira H.

Obes Facts. 2015;8(4):234-42. doi: 10.1159/000436997. Epub 2015 Jul 1.

7.

Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.

Takahashi A, Abe K, Usami K, Imaizumi H, Hayashi M, Okai K, Kanno Y, Tanji N, Watanabe H, Ohira H.

Int J Sports Med. 2015 Oct;36(10):848-52. doi: 10.1055/s-0035-1549853. Epub 2015 Jun 19.

PMID:
26090879
8.

Circulating Cytokine Levels in Patients with Prostate Cancer: Effects of Neoadjuvant Hormonal Therapy and External-beam Radiotherapy.

Tanji N, Kikugawa T, Ochi T, Taguchi S, Sato H, Sato T, Sugahara T, Hamada H, Asai S, Matsumoto A.

Anticancer Res. 2015 Jun;35(6):3379-83.

PMID:
26026098
9.

Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.

Asai S, Fukumoto T, Tanji N, Miura N, Miyagawa M, Nishimura K, Yanagihara Y, Shirato A, Miyauchi Y, Kikugawa T, Yokoyama M.

Int J Clin Oncol. 2015 Oct;20(5):1042-7. doi: 10.1007/s10147-015-0817-4. Epub 2015 Mar 21.

PMID:
25794920
10.

Long‑term exposure to leptin enhances the growth of prostate cancer cells.

Noda T, Kikugawa T, Tanji N, Miura N, Asai S, Higashiyama S, Yokoyama M.

Int J Oncol. 2015 Apr;46(4):1535-42. doi: 10.3892/ijo.2015.2845. Epub 2015 Jan 23.

PMID:
25625287
11.

Age-dependent changes in damage processes of hair cuticle.

Takahashi T, Mamada A, Breakspear S, Itou T, Tanji N.

J Cosmet Dermatol. 2015 Mar;14(1):2-8. doi: 10.1111/jocd.12129. Epub 2015 Jan 7.

PMID:
25580990
12.

[Clinicopathologic characteristics and prognosis of patients with adrenocortical carcinoma].

Miura N, Ide T, Uda T, Noda T, Asai S, Nishimura K, Shirato A, Yanagihara Y, Miyauchi Y, Kikugawa T, Tanji N, Yokoyama M.

Nihon Hinyokika Gakkai Zasshi. 2014 Jul;105(3):79-84. Japanese.

PMID:
25158548
13.

Modified FOLFOX6 chemotherapy in patients with metastatic urachal cancer.

Yanagihara Y, Tanji N, Miura N, Shirato A, Nishimura K, Fukumoto T, Azuma K, Miyauchi Y, Kikugawa T, Yokoyama M.

Chemotherapy. 2013;59(6):402-6. doi: 10.1159/000362400. Epub 2014 Jun 25.

PMID:
24969043
14.

Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells.

Shirato A, Kikugawa T, Miura N, Tanji N, Takemori N, Higashiyama S, Yokoyama M.

Oncol Lett. 2014 Mar;7(3):674-678. Epub 2013 Dec 19.

15.

[A case of neurosurgery for meningioma in a chronic hemodialysis patient: perioperative management of chronic hemodialysis patients requiring neurosurgery].

Inoue A, Harada H, Miura N, Nishikawa M, Fukumoto T, Kohno S, Ohue S, Tanji N, Ohnishi T.

No Shinkei Geka. 2013 Dec;41(12):1087-92. Japanese.

PMID:
24317885
16.

Combined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency.

Tanji N, Fukumoto T, Miura N, Yanagihara Y, Shirato A, Azuma K, Miyauchi Y, Kikugawa T, Shimamoto K, Yokoyama M.

Int J Clin Oncol. 2013 Oct;18(5):910-5. doi: 10.1007/s10147-012-0466-9. Epub 2012 Aug 31.

PMID:
22936563
17.

Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.

Miura N, Takemori N, Kikugawa T, Tanji N, Higashiyama S, Yokoyama M.

Mol Oncol. 2012 Jun;6(3):311-22. doi: 10.1016/j.molonc.2011.12.002. Epub 2012 Jan 4.

18.

Potential of histone deacetylase inhibitors for bladder cancer treatment.

Tanji N, Ozawa A, Kikugawa T, Miura N, Sasaki T, Azuma K, Yokoyama M.

Expert Rev Anticancer Ther. 2011 Jun;11(6):959-65. doi: 10.1586/era.10.230. Review.

PMID:
21707293
19.

[Low-dose docetaxel in combination with dexamethasone for hormone-refractory prostate cancer].

Yanagihara Y, Miura N, Azuma K, Sasaki T, Nishida T, Kikugawa T, Sato H, Shimamoto K, Aoki K, Tanji N, Takeda H, Yokoyama M.

Nihon Hinyokika Gakkai Zasshi. 2011 Jan;102(1):23-7. Japanese.

PMID:
21520633
20.

Treatment of metastatic renal cell carcinoma and renal pelvic cancer.

Tanji N, Yokoyama M.

Clin Exp Nephrol. 2011 Jun;15(3):331-338. doi: 10.1007/s10157-011-0438-9. Epub 2011 Apr 12. Review.

PMID:
21479988
21.

Spontaneous regression of metastatic renal cancer after short-term treatment with sunitinib.

Yanagihara Y, Tanji N, Nishida T.

Int J Urol. 2011 Mar;18(3):258-9. doi: 10.1111/j.1442-2042.2010.02715.x. No abstract available.

22.

Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over.

Tanji N, Fukumoto T, Miura N, Yanagihara Y, Azuma K, Sasaki T, Nishida T, Kikugawa T, Shimamoto K, Aoki K, Yokoyama M.

Anticancer Res. 2010 Sep;30(9):3839-43.

PMID:
20944180
23.

Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Sakayama K, Sugawara Y, Kidani T, Fujibuchi T, Kito K, Tanji N, Nakamura A.

Int J Clin Oncol. 2011 Jun;16(3):270-4. doi: 10.1007/s10147-010-0127-9. Epub 2010 Sep 29.

PMID:
20878436
24.

Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.

Sasaki T, Nakashiro K, Tanaka H, Azuma K, Goda H, Hara S, Onodera J, Fujimoto I, Tanji N, Yokoyama M, Hamakawa H.

Biochem Biophys Res Commun. 2010 Aug 13;399(1):79-83. doi: 10.1016/j.bbrc.2010.07.045. Epub 2010 Jul 16.

PMID:
20638364
25.

18-MEA and hair appearance.

Tanamachi H, Tokunaga S, Tanji N, Oguri M, Inoue S.

J Cosmet Sci. 2010 Mar-Apr;61(2):147-60.

PMID:
20447366
26.

[Case report: simultaneous bilateral testicular tumors with different cell types].

Yanagihara Y, Sawada Y, Ozaw A, Nishid T, Kikugawa T, Ikeda T, Shimamoto K, Aoki K, Tanji N, Iio S, Yokoyam M.

Nihon Hinyokika Gakkai Zasshi. 2010 Mar;101(3):574-8. Japanese.

PMID:
20387519
27.

Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.

Tanji N, Ozawa A, Miura N, Yanagihara Y, Sasaki T, Nishida T, Kikugawa T, Ikeda T, Ochi T, Shimamoto K, Aoki K, Yokoyama M.

Int J Clin Oncol. 2010 Aug;15(4):369-75. doi: 10.1007/s10147-010-0069-2. Epub 2010 Mar 26.

PMID:
20340038
28.

Anti-tumor effect of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cells.

Azuma K, Nakashiro K, Sasaki T, Goda H, Onodera J, Tanji N, Yokoyama M, Hamakawa H.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):1075-9. doi: 10.1016/j.bbrc.2009.12.024. Epub 2009 Dec 14.

PMID:
20004643
29.

Reconstruction using a frozen bone method for osteosarcoma of the talus. A case report and review of the literature.

Sakayama K, Kidani T, Sugawara Y, Tauchi H, Fujibuchi T, Tanji N, Yamamoto H, Tsuchiya H.

Anticancer Res. 2009 Oct;29(10):4093-8.

30.

A role of the anteiso branch of 18-MEA in 18-MEA/SPDA to form a persistent hydrophobicity to alkaline-color-treated weathered hair.

Tanamachi H, Inoue S, Tokunaga S, Tsujimura H, Tanji N, Oguri M, Habe T.

J Cosmet Sci. 2009 Sep-Oct;60(5):509-18.

PMID:
19822108
31.

Inhibition of bladder tumour growth by histone deacetylase inhibitor.

Ozawa A, Tanji N, Kikugawa T, Sasaki T, Yanagihara Y, Miura N, Yokoyama M.

BJU Int. 2010 Apr;105(8):1181-6. doi: 10.1111/j.1464-410X.2009.08795.x. Epub 2009 Aug 13.

32.

[Intrascrotal rhabdomyosarcoma in adult: a case report].

Shimamoto K, Tanji N, Ozaw A, Sasaki T, Ikeda T, Iseda T, Yokoyama M.

Nihon Hinyokika Gakkai Zasshi. 2009 May;100(4):545-9. Japanese.

PMID:
19514277
33.

A signaling network in phenylephrine-induced benign prostatic hyperplasia.

Kim J, Yanagihara Y, Kikugawa T, Ji M, Tanji N, Masayoshi Y, Freeman MR.

Endocrinology. 2009 Aug;150(8):3576-83. doi: 10.1210/en.2008-1782. Epub 2009 May 14.

34.

Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.

Hyodo T, Sugawara Y, Tsuda T, Yanagihara Y, Aoki K, Tanji N, Hirata M, Murakami M, Miyagawa M, Yokoyama M, Mochizuki T.

Jpn J Radiol. 2009 Feb;27(2):111-4. doi: 10.1007/s11604-008-0305-0. Epub 2009 Mar 12.

PMID:
19373542
35.

Deposition of 18-MEA onto alkaline-color-treated weathered hair to form a persistent hydrophobicity.

Tanamachi H, Inoue S, Tanji N, Tsujimura H, Oguri M, Ishita M, Tokunaga S, Sazanami F.

J Cosmet Sci. 2009 Jan-Feb;60(1):31-44. Erratum in: J Cosmet Sci. 2009 Sep-Oct;60(5):517-8.

PMID:
19296894
36.

The synthesis and activity of lipoprotein lipase in the subcutaneous adipose tissue of patients with musculoskeletal sarcomas.

Sakayama K, Kidani T, Tanji N, Yamamoto H, Masuno H.

Anticancer Res. 2008 Jul-Aug;28(4B):2081-6.

37.

Androgens upregulate aquaporin 9 expression in the prostate.

Wang J, Tanji N, Sasaki T, Kikugawa T, Song X, Yokoyama M.

Int J Urol. 2008 Oct;15(10):936-41. doi: 10.1111/j.1442-2042.2008.02130.x. Epub 2008 Aug 20.

38.

Malignant salivary gland-type mixed tumour of the kidney.

Miyauchi Y, Tanji N, Miyazaki T, Shimamoto K, Sakayama K, Yokoyama M.

Pathology. 2008 Jun;40(4):431-4. doi: 10.1080/00313020802036822. No abstract available.

PMID:
18446643
39.

Expression of aquaporin 3 in the human prostate.

Wang J, Tanji N, Kikugawa T, Shudou M, Song X, Yokoyama M.

Int J Urol. 2007 Dec;14(12):1088-92; discussion 1092.

40.

Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience.

Ozawa A, Tanji N, Ochi T, Yanagihara Y, Kikugawa T, Yamaguchi A, Ikeda T, Shimamoto K, Aoki K, Toshino A, Yokoyama M.

Int J Clin Oncol. 2007 Aug;12(4):279-83. Epub 2007 Aug 20.

PMID:
17701007
41.

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, Tozawa K, Kohri K, Tanji N, Yokoyama M, Shimazui T, Akaza H, Mizutani Y, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H.

Cancer Res. 2007 Jun 1;67(11):5117-25.

42.

MPAI (mass probes aided ionization) method for total analysis of biomolecules by mass spectrometry.

Honda A, Hayashi S, Hifumi H, Honma Y, Tanji N, Iwasawa N, Suzuki Y, Suzuki K.

Anal Sci. 2007 Jan;23(1):11-5. Review.

43.

[A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy].

Shirato A, Shimamoto K, Ozawa A, Tanji N, Yokoyama M.

Gan To Kagaku Ryoho. 2006 Dec;33(13):2097-9. Japanese.

PMID:
17197762
44.

Pathological findings of an autograft containing osteosarcoma treated by liquid nitrogen retrieved 2 years after implantation.

Sakayama K, Tsuchiya H, Fujibuchi T, Kidani T, Tanji N, Yamamoto H.

J Orthop Sci. 2006 Nov;11(6):655-6. Epub 2006 Dec 4. No abstract available.

PMID:
17139478
45.

Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.

Wada T, Tanji N, Ozawa A, Wang J, Shimamoto K, Sakayama K, Yokoyama M.

Anticancer Res. 2006 Sep-Oct;26(5A):3403-8.

46.

A case of nodular-type muscular sarcoidosis: findings of imaging, histopathology, and polymerase chain reaction.

Sakayama K, Sugawara Y, Fujibuchi T, Sada E, Kidani T, Miyawaki J, Tanji N, Yamamoto H.

Mod Rheumatol. 2005;15(2):114-7.

PMID:
17029046
47.

[Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)].

Ochi T, Ozawa A, Tanji N, Yanagihara Y, Yanagaki T, Miyauchi Y, Ikeda T, Shimamoto K, Toshino A, Sugawara T, Hamada H, Yokoyama M.

Nihon Hinyokika Gakkai Zasshi. 2006 Sep;97(6):777-81. Japanese.

48.

Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells.

Maeda A, Nakashiro K, Hara S, Sasaki T, Miwa Y, Tanji N, Yokoyama M, Hamakawa H, Oyasu R.

Biochem Biophys Res Commun. 2006 Sep 8;347(4):1158-65. Epub 2006 Jul 17.

PMID:
16870139
49.

Mycotic aneurysm of the renal transplant artery.

Fujikata S, Tanji N, Iseda T, Ohoka H, Yokoyama M.

Int J Urol. 2006 Jun;13(6):820-3.

50.

Primary retroperitoneal lymphocele in a pregnant woman: the first report.

Ikeda T, Miyauchi Y, Nishio S, Shimamoto K, Tanji N, Yokoyama M.

Int J Urol. 2006 Apr;13(4):445-6.

Supplemental Content

Support Center